Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.

"Exelixis and MSD to trial cancer therapies together in clinical collaboration" was originally created and published by ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

Just how much pain do you have to endure to benefit from weight training? Fitness experts say that depends on what you’re trying to accomplish. For years, some trainers have ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...

Exelixis, an Alameda, Calif., oncology company, and Rahway, N.J., drugmaker Merck said they also plan a Phase 1/2 trial and two Phase 3 studies of zanzalintinib in combination with Merck's Welireg in ...

During a Case-Based Roundtable® event, Chandler Park, MD, moderated a discussion on how recent trial data and sites of ...

A severe solar storm is headed to Earth that could stress power grids even more as the US deals with disruptions from Hurricane Milton that hit Florida .

Treatment with belzutifan (Welireg) showed significant benefits over everolimus (Afinitor) for advanced RCC, enhancing PFS and objective response rate (ORR). However, the LITESPARK-005 trial ...